https://www.bioworld.com/articles/496648-regulator
Post# of 148278
Announced it will submit requests for pre-submission meetings in the U.K. for leronlimab as an HIV treatment in combination with HAART for highly treatment-experienced HIV patients, as well as for emergency approval for COVID-19 patients with mild to moderate symptoms